Skip to main content
Funded Studies

Kim Amelia Stockwell, PhD, BSc

Senior Scientist at Proximagen Neuroscience, PLC

Location: London United Kingdom

Dr. Stockwell has over 12 years research experience focusing primarily on investigating potential anti-dyskinesiogenic and neuroprotective therapies in in vivo and in vitro models of Parkinson’s disease. She obtained her PhD from King’s College London working with Professor Peter Jenner at the Neurodegenerative Diseases Research Centre before joining Proximagen when it was founded – a spin-out company from Peter Jenner’s group.

Associated Grants

  • Dopamine D1 Positive Modulators for the Treatment of Parkinson's Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.